
    
      The purpose of this trial is to investigate the effects of the three strain probiotic,
      Kyo-Dophilus, on the symptoms associated with Irritable Bowel Syndrome.

      The primary objective of this trial is to determine the effectiveness of Kyo-Dophilus on the
      symptoms associated with Irritable Bowel Syndrome in an adult population diagnosed with
      Irritable Bowel Syndrome by ROME III criteria and classified as mild through the Irritable
      Bowel Severity Scoring System and to measuring quality of life and global well being of
      patients through the Visual Analog Scale and the Irritable Bowel Syndrome-Quality of Life
      Questioner. The secondary objective is to assess the tolerability of the treatment through
      the use of study diaries.
    
  